Source:http://linkedlifedata.com/resource/pubmed/id/21544957
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2011-5-5
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0079-6468
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
31-80
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
The identification of and rationale for drugs which act at the motilin receptor.
|
pubmed:affiliation |
Immuno-Inflammation CEDD, GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts SG1 2NY, UK.
|
pubmed:publicationType |
Journal Article,
Review
|